A detailed history of Bensler, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Bensler, LLC holds 16,873 shares of ZTS stock, worth $3.08 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
16,873
Previous 17,217 2.0%
Holding current value
$3.08 Million
Previous $2.98 Billion 10.45%
% of portfolio
0.42%
Previous 0.4%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$172.58 - $196.48 $59,367 - $67,589
-344 Reduced 2.0%
16,873 $3.3 Billion
Q2 2024

Jul 26, 2024

SELL
$145.54 - $178.83 $52,248 - $64,199
-359 Reduced 2.04%
17,217 $2.98 Billion
Q1 2024

Apr 30, 2024

SELL
$165.67 - $199.94 $49,038 - $59,182
-296 Reduced 1.66%
17,576 $2.97 Billion
Q4 2023

Jan 22, 2024

SELL
$151.44 - $200.09 $121,909 - $161,072
-805 Reduced 4.31%
17,872 $3.53 Billion
Q3 2023

Oct 25, 2023

BUY
$167.14 - $192.77 $43,289 - $49,927
259 Added 1.41%
18,677 $3.25 Billion
Q2 2023

Jul 20, 2023

SELL
$160.94 - $186.23 $73,549 - $85,107
-457 Reduced 2.42%
18,418 $3.17 Billion
Q1 2023

Apr 27, 2023

SELL
$145.48 - $175.02 $16,730 - $20,127
-115 Reduced 0.61%
18,875 $3.14 Billion
Q4 2022

Feb 16, 2023

BUY
$131.14 - $157.47 $179,137 - $215,104
1,366 Added 7.75%
18,990 $2.78 Billion
Q3 2022

Feb 16, 2023

BUY
$148.29 - $182.55 $75,479 - $92,917
509 Added 2.97%
17,624 $2.61 Billion
Q2 2022

Feb 16, 2023

BUY
$155.97 - $200.09 $228,184 - $292,731
1,463 Added 9.35%
17,115 $2.94 Billion
Q1 2022

Feb 16, 2023

BUY
$181.39 - $234.03 $202,612 - $261,411
1,117 Added 7.68%
15,652 $2.95 Billion
Q4 2021

Feb 16, 2023

BUY
$193.69 - $247.03 $2.82 Million - $3.59 Million
14,535 New
14,535 $3.55 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bensler, LLC Portfolio

Follow Bensler, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bensler, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bensler, LLC with notifications on news.